How Neurotransmitters Work — The Brain's Chemical Messengers

Your brain contains roughly 86 billion neurons, and almost none of them touch each other. Between the end of one neuron and the beginning of the next lies a gap called a synapse — about 20 nanometers wide, a fraction of the diameter of a human hair. Neurons communicate across this gap using chemical signals called neurotransmitters.

These molecules orchestrate virtually everything your brain does: thinking, feeling, moving, sleeping, remembering, and even who you are. Disruptions in neurotransmitter systems underlie depression, anxiety, schizophrenia, Parkinson's disease, addiction, and dozens of other conditions. Most psychiatric and neurological drugs work by modifying these systems.

What Is a Neurotransmitter?

A neurotransmitter is a chemical released by one neuron that binds to receptors on another neuron (or muscle, or gland), either exciting it or inhibiting it. To qualify as a neurotransmitter, a molecule must be:

1. Synthesized inside the neuron
2. Released in response to electrical stimulation (an action potential)
3. Able to bind specific receptors on the target cell and produce a response
4. Inactivated after use (by reuptake, enzymatic breakdown, or diffusion)

The human brain uses over 100 different neurotransmitters, though a handful account for most of the traffic.

How Synaptic Transmission Works

Understanding neurotransmitters requires understanding the synapse — the junction where neurons communicate.

Step 1 — Action potential arrives. An electrical signal (action potential) travels down the axon of the "sending" neuron (presynaptic neuron) to the axon terminal.

Step 2 — Calcium floods in. The action potential opens voltage-gated calcium channels. Calcium ions rush into the terminal.

Step 3 — Vesicles fuse and release. Synaptic vesicles — tiny membrane sacs packed with neurotransmitter molecules — merge with the cell membrane and dump their contents into the synaptic cleft.

Step 4 — Neurotransmitters bind receptors. Neurotransmitter molecules diffuse across the cleft and bind to receptor proteins on the membrane of the "receiving" neuron (postsynaptic neuron).

Step 5 — Receptor opens or activates. Depending on the receptor type, binding either opens ion channels directly (ionotropic receptors, fast) or triggers a signaling cascade through G-proteins (metabotropic receptors, slow). This either depolarizes the postsynaptic neuron (excitatory) or hyperpolarizes it (inhibitory).

Step 6 — Termination. The signal stops via:

• Reuptake — transporter proteins pull neurotransmitter back into the presynaptic neuron for recycling.
• Enzymatic degradation — enzymes break the neurotransmitter down (e.g., monoamine oxidase breaks down dopamine and serotonin).
• Diffusion — the molecule drifts away from the synapse.

The Major Neurotransmitters

Glutamate — The Main Excitatory Signal

Glutamate is the most abundant neurotransmitter in the brain and the primary excitatory signal. It's active in circuits for learning, memory, and sensory processing. When glutamate binds NMDA receptors — a key subtype — it allows calcium to enter the postsynaptic neuron, triggering a cascade that can strengthen the synapse. This process — long-term potentiation (LTP) — is considered the cellular basis of learning and memory.

Too much glutamate is toxic. Excitotoxicity — overstimulation by glutamate during a stroke or traumatic brain injury — kills neurons by flooding them with calcium. Many drugs being developed for neurodegenerative disease target glutamate excess.

Ketamine, widely used as an anesthetic and increasingly as a rapid antidepressant, works primarily by blocking NMDA receptors.

GABA — The Main Inhibitory Signal

GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter. It works as a brake system, reducing neural excitability throughout the nervous system. Without sufficient GABA activity, neurons fire too easily — a central mechanism of epilepsy.

GABA acts on two main receptor types:

• GABA-A (ionotropic): opens chloride channels, causing rapid inhibition. Target of benzodiazepines (Valium, Xanax), barbiturates, and alcohol — all of which enhance GABA-A activity, producing sedation and anxiety relief.
• GABA-B (metabotropic): slower, longer-lasting inhibition. Baclofen (used for muscle spasticity) works here.

For more on how sedatives interact with GABA, see our article on how alcohol affects the brain.

Dopamine — Motivation and Reward

Dopamine is one of the most discussed neurotransmitters in popular culture, usually described as the "pleasure chemical." This is a simplification. Dopamine's primary role is in motivation, prediction, and reward learning — it signals not pleasure itself, but the expectation of reward and the error between expectation and outcome.

Key dopamine pathways:

• Mesolimbic pathway (ventral tegmental area → nucleus accumbens) — motivation, reward, addiction
• Mesocortical pathway (VTA → prefrontal cortex) — cognition, working memory
• Nigrostriatal pathway (substantia nigra → striatum) — movement control; this pathway degenerates in Parkinson's disease
• Tuberoinfundibular pathway — regulates prolactin release

Dopamine is central to addiction: drugs like cocaine (blocks dopamine reuptake) and amphetamines (force dopamine release) flood the reward pathway with dopamine, creating the intense reinforcement that drives dependence. For a deep dive into the dopamine system, see our article on how dopamine really works.

Serotonin — Mood, Sleep, and Appetite

Serotonin (5-hydroxytryptamine, 5-HT) is synthesized primarily in the raphe nuclei of the brainstem and projected throughout the brain. About 90% of the body's serotonin is actually in the gut, where it regulates intestinal movement.

In the brain, serotonin influences:

• Mood and emotional regulation — low serotonin tone correlates with depression and anxiety (though the relationship is more complex than the old "chemical imbalance" model suggests)
• Sleep — serotonin is a precursor to melatonin; raphe activity varies across the sleep cycle
• Appetite — serotonin suppresses hunger; weight loss drugs targeting 5-HT2C receptors exploit this
• Social behavior — serotonin modulates aggression and social hierarchy behavior across species

SSRIs (selective serotonin reuptake inhibitors) — the most widely prescribed antidepressants (fluoxetine/Prozac, sertraline/Zoloft) — work by blocking serotonin reuptake transporters, increasing serotonin availability in synapses. The effect on depression is real but modest for most patients, and the mechanism is more nuanced than simply "raising serotonin levels." For the neuroscience of depression, see our depression neuroscience article.

Acetylcholine — Attention, Learning, and Muscle Control

Acetylcholine (ACh) was the first neurotransmitter discovered (by Otto Loewi in 1921). It operates in two distinct contexts:

Central nervous system: ACh is released from basal forebrain neurons throughout the cortex and hippocampus, promoting attention, arousal, and memory consolidation. The basal forebrain cholinergic neurons are among the first to degenerate in Alzheimer's disease, explaining early deficits in memory and attention. Drugs like donepezil (Aricept) block the enzyme (acetylcholinesterase) that breaks down ACh, temporarily boosting levels — the main pharmacological approach to Alzheimer's symptoms.

Peripheral nervous system: ACh is the neurotransmitter at neuromuscular junctions — the synapses between motor neurons and muscle fibers. When ACh binds nicotinic receptors on muscle, the muscle contracts. Curare (used in surgical paralysis) blocks these receptors; nerve agents like sarin (and the toxin in botulinum toxin, botox) disrupt this system with lethal or paralyzing results.

Norepinephrine (Noradrenaline) — Alertness and the Stress Response

Norepinephrine (NE) is released from the locus coeruleus in the brainstem and projects widely across the brain. It's the neurotransmitter of alertness, attention, and the fight-or-flight response. NE increases heart rate, blood pressure, and glucose availability during stress.

In the brain, NE modulates:

• Arousal and attention
• Working memory
• Emotional processing (particularly fear and threat responses)

SNRIs (serotonin-norepinephrine reuptake inhibitors, like venlafaxine and duloxetine) block both serotonin and norepinephrine reuptake, and are used for depression and anxiety disorders. NE is also a key target in ADHD medications: atomoxetine (Strattera) selectively blocks NE reuptake in the prefrontal cortex.

Endorphins — Natural Pain Relief

Endorphins (endogenous morphine) are neuropeptides — larger molecules than classical neurotransmitters — that bind opioid receptors to reduce pain and produce feelings of euphoria. The famous "runner's high" involves endorphin release. Morphine and heroin mimic endorphins at these receptors, which is why they are powerful painkillers and equally powerful drugs of abuse.

Comparison: Major Neurotransmitters at a Glance

Neurotransmitter	Type	Primary Action	Key Functions	Notable Disorders/Drugs
Glutamate	Amino acid	Excitatory	Learning, memory, sensory processing	Stroke excitotoxicity; ketamine blocks NMDA
GABA	Amino acid	Inhibitory	Anxiety reduction, muscle relaxation	Epilepsy; benzodiazepines, alcohol enhance GABA-A
Dopamine	Monoamine	Excitatory/modulatory	Reward, motivation, movement	Parkinson's (nigrostriatal loss); addiction; antipsychotics
Serotonin	Monoamine	Modulatory	Mood, sleep, appetite	Depression, OCD; SSRIs block reuptake
Acetylcholine	Ester	Excitatory	Attention, memory, muscle contraction	Alzheimer's (cholinergic loss); botulinum, nerve agents
Norepinephrine	Monoamine	Excitatory/modulatory	Alertness, stress, attention	ADHD, depression; SNRIs, beta-blockers
Endorphins	Neuropeptide	Inhibitory	Pain relief, euphoria	Pain; opioids mimic them

When Neurotransmitter Systems Go Wrong

Most psychiatric and neurological drugs work by modifying neurotransmitter activity — either amplifying signals (agonists) or reducing them (antagonists). This is why understanding neurotransmitters matters clinically:

• Parkinson's disease — loss of dopaminergic neurons in the substantia nigra causes motor symptoms. L-DOPA (a dopamine precursor) partially restores the signal.
• Schizophrenia — excess dopamine activity in mesolimbic pathways (positive symptoms); antipsychotics are dopamine D2 receptor blockers.
• Depression — complex dysregulation of serotonin, norepinephrine, and glutamate circuits; NMDA antagonism (ketamine) produces rapid antidepressant effects, suggesting glutamate is as important as monoamines.
• Anxiety disorders — excessive norepinephrine and insufficient GABA tone; treated with benzodiazepines (GABA enhancers) and SSRIs/SNRIs.
• ADHD — reduced dopamine and norepinephrine activity in prefrontal circuits; stimulants increase dopamine and NE release.

FAQ

Q: What is the difference between a neurotransmitter and a hormone? A: Neurotransmitters act locally at synapses — they cross tiny gaps between adjacent neurons and their effects are fast and specific. Hormones are released into the bloodstream and travel to distant target organs, working more slowly and broadly. Some molecules, like epinephrine (adrenaline) and norepinephrine, act as both — they are neurotransmitters in the brain and hormones when secreted by the adrenal glands.

Q: Can you increase serotonin or dopamine naturally? A: Yes, modestly. Exercise increases dopamine and serotonin release and upregulates receptors. Sunlight exposure promotes serotonin synthesis. Good sleep restores neurotransmitter stores. Tryptophan-rich foods (turkey, eggs, cheese) provide serotonin's precursor. These effects are real but modest compared to drugs targeting reuptake transporters.

Q: Do antidepressants work by fixing a "chemical imbalance"? A: The "serotonin deficiency = depression" model is an oversimplification that has been largely revised. SSRIs raise synaptic serotonin within hours, but therapeutic effects take weeks — suggesting the antidepressant mechanism involves downstream changes in receptor sensitivity, neuroplasticity, and brain circuit remodeling rather than simply correcting a deficiency.

Q: Is dopamine really about pleasure? A: Not exactly. Dopamine primarily signals anticipated reward and prediction errors — the gap between what you expected and what actually happened. Experiencing pleasure involves dopamine but also opioid systems, cannabinoid systems, and others. You can have dopamine firing without feeling pleasure (anhedonia in depression involves exactly this dissociation).

Q: How do recreational drugs affect neurotransmitters? A: Most work by hijacking the neurotransmitter system. Cocaine and MDMA block dopamine/serotonin reuptake transporters. Heroin mimics endorphins. Alcohol enhances GABA-A and blocks NMDA receptors. LSD mimics serotonin at 5-HT2A receptors. Cannabis activates cannabinoid receptors that normally respond to endocannabinoids (like anandamide). All create intense, unnatural surges that the brain adapts to — the basis of tolerance and dependence.

Sources

• Purves, D., et al. Neuroscience, 6th edition. Sinauer Associates, 2018.
• Stahl, S. M. Stahl's Essential Psychopharmacology, 4th edition. Cambridge University Press, 2013.
• Schultz, W. (2007). Behavioral dopamine signals. Trends in Neurosciences, 30(5), 203–210.
• Bliss, T. V., & Collingridge, G. L. (1993). A synaptic model of memory: LTP. Nature, 361, 31–39.
• Moncrieff, J., et al. (2022). The serotonin theory of depression: a systematic umbrella review. Molecular Psychiatry.